Polyamines can also inhibit the expression of NK1.1 receptors of NK cells and the production of perforin and IFN-γ, thus attenuating NK cell-mediated tumor cell recognition and cytolysis, and such effects could be reversed by treatment with DFMO, rosuvastatin, and their combination (182). This evidence concerns the gene PRF1 and neoplasm.